Home

Case Study

Reducing Time to Launch Evidence Generation by Easily Identifying and Pre-qualifying Relevant Data Assets

Reducing Time to Launch Evidence Generation by Easily Identifying and Pre-qualifying Relevant Data Assets

IQVIA
Pages 1 Pages

A large pharma company in rare diseases leveraged IQVIA’s Health Data Catalog to build a repository of 70+ data sources across 30 countries within minutes. The platform enabled real-time refreshes and harmonization, ensuring quality and timeliness of information. This repository supports RWE generation for trial optimization and patient pathway analysis. The case highlights IHDC’s role in reducing delays, improving accuracy, and enabling faster, more effective evidence generation.

Join for free to read

You Might Also Like


Generating evidence for digital health solutions
White Paper Generating evidence for digital health solutions
Roche Diagnostics International

Reducing Time to Insight and Maximizing the Benefits of Real-Time Data
Report Reducing Time to Insight and Maximizing the Benefits of…
zoominfo

Improving Launch by Identifying and Profiling the Most Relevant KOLs
Case Study Improving Launch by Identifying and Profiling the Most Relevant…
IQVIA

Rethink risk with evidence-based security
Ebook Rethink risk with evidence-based security
Verizon Business

More from IQVIA


Improving Launch by Identifying and Profiling the Most Relevant KOLs
Case Study Improving Launch by Identifying and Profiling the Most Relevant…
IQVIA

Enriching Evidence Generation in Healthcare
White Paper Enriching Evidence Generation in Healthcare
IQVIA

USING AI & MACHINE LEARNING TO DRIVE COMMERCIAL SUCCESS IN THE EU
White Paper USING AI & MACHINE LEARNING TO DRIVE COMMERCIAL SUCCESS IN THE EU
IQVIA

Digital Health Evidence Generation Strategy
Vendor Sheet Digital Health Evidence Generation Strategy
IQVIA
© 2025 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info